GTX-758 is under investigation in clinical trial NCT01420861 (GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.